This segment focuses on the research, development, and commercialization of pharmaceutical products targeting cardio-cerebrovascular and gastroenterological diseases. The company leverages its expertise in drug formulation, clinical trials, and regulatory affairs to bring innovative therapies to market. This includes products like Plendil for hypertension and XinHuoSu for acute heart failure. The segment's market positioning benefits from the growing demand for treatments in these areas, particularly in China, and the company's established distribution network. Future opportunities lie in expanding the product portfolio and exploring new therapeutic applications. The segment is also involved in partnerships and collaborations to enhance its product offerings and market reach.

This segment concentrates on the development, marketing, and sales of pharmaceutical products for dermatological and ophthalmological conditions. The company's research and development efforts focus on creating innovative formulations and delivery systems to improve patient outcomes. This includes products like Augentropfen Stulln Mono eye drops and Hirudoid for various skin conditions. The segment benefits from the increasing prevalence of these conditions and the company's strong presence in the Chinese market. Future growth opportunities include expanding the product pipeline, entering new markets, and leveraging digital health technologies to improve patient care. The segment also actively seeks partnerships to enhance its product offerings and market access.

This segment is dedicated to the research, development, and commercialization of pharmaceutical products for respiratory and metabolic diseases. The company's R&D activities include the development of new drug formulations, clinical trials, and regulatory submissions. This segment includes products like YiNuoShu for respiratory diseases and MOVICOL for chronic constipation. The company's market position is strengthened by its established distribution network and strong relationships with healthcare professionals. Future opportunities include expanding the product portfolio, exploring new therapeutic areas, and leveraging technological advancements to improve patient outcomes. The segment also actively seeks partnerships to enhance its product offerings and market access.